Retinal Neovascularization, Unspecified
1 clinical trials · Condition
◉ Watch Retinal Neovascularization, Unspecified
| Record | Firm | Date |
|---|---|---|
| Feasibility Study and Preliminary Application Study on Iris OCTA (NCT03631108) | Shanghai Eye Disease Prevention and Treatment Center | 2018-10-01 |
Track Retinal Neovascularization, Unspecified automatically
Every clearance here is in the API, with alerts when new ones post.